95301 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#302Fused Heterobicyclic Antiviral Agents
#303BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF
#304RAD51 INHIBITORS
#305SMALL MOLECULE UREA DERIVATIVES AS STING ANTAGONISTS
#306HETEROCYCLIC COMPOUNDS AS SEROTONIN (5-HT) 5-HT2A AND 5-HT2C RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#307Glucose Uptake Inhibitors
#308THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#309SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS
#310SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES
#311NOVEL PARP7 INHIBITOR AND USE THEREOF
#312MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS
#313MALEATE SALT OF THE FREE BASE OF N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE, PHARMACEUTICAL FORMULATIONS, METHODS OF MANUFACTURE AND USES THEREOF
#314SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES
#315CRYSTAL FORM OF LANIFIBRANOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#316SUBSTITUTED HETEROCYCLES AS ALDEHYDE DEHYDROGENASE INHIBITORS
#317PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF
#318PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT
#319IL4I1 INHIBITORS AND METHODS OF USE
#320Heterocycle derivatives for treating TRPM3 mediated disorders
#321CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS
#322METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE
#323Modulators of mas-related g-protein receptor X2 and related products and methods
#324SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)
#325HETEROARYL-THIO-SUBSTITUTED PYRONES
#326Compositions and methods for making and using small molecules for tubulin-targeted therapy in the treatment of cancers and related conditions
#327Covalent Inhibitors As Antiviral Agents
#328PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
#329CYCLOPROPANAMINE COMPOUND AND USE THEREOF
#330A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13
#331Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
#332SUBSTITUTED HETEROCYCLIC COMPOUNDS
#333INHIBITORS OF TRANSGLUTAMINASES
#334Chemokine CXCR4 Receptor Modulators and Uses Related Thereto
#335NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS
#336NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR
#3371,3-SUBSTITUTED CYCLOBUTYL DERIVATIVES AND USES THEREOF
#338UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER
#3392-aminothiazoles derivatives and method of preparation thereof using super-paramagnetic iron oxide nanoparticles (SPIONs)
#340Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#3413-PYRROLYLSULFONAMIDE COMPOUNDS AS GPR17 ANTAGONISTS
#342Arylamine compound, organic electroluminescent device, and electronic apparatus
#343Drp-1 inhibitors as therapeutic agents
#344COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO
#345NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR
#346TRIAZOLE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS
#347COMPOSITIONS AND METHODS FOR TREATING CANCER
#348O-LINKED THIADIAZOLYL COMPOUNDS AS DNA POLYMERASE THETA INHIBITORS
#349PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#350MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES
#351INDOLE COMPOUNDS AND METHODS OF USE
#352Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins
#353DUAL WNT SIGNALING PATHWAY INHIBITORS AND AMPK ACTIVATORS FOR TREATMENTS OF DISEASE
#354ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#355Aryl-or heteroaryl-substituted benzene compounds
#356PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#357UREA COMPOUNDS AND COMPOSITIONS AS SMARCA2/BRM ATPASE INHIBITORS
#358SMALL MOLECULAR INHIBITORS OF STING SIGNALING COMPOSITIONS AND METHODS OF USE
#359MACROCYCLIC HETEROCYCLES AND USES THEREOF
#360COMPOUNDS AND METHODS FOR TARGETING PATHOGENIC BLOOD VESSELS
#3613-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES
#362QUINAZOLINE DERIVATIVES TARGETING R(CCUG) REPEATS IN MYOTONIC DYSTROPHY TYPE 2
#363METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-HYDROXY-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE BY HYDROGENATION OF THE 2-OXO DERIVATIVE IN THE PRESENCE OF A CHIRAL TRANSITION METAL CATALYST
#364N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF
#365COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES
#366SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE
#367BENZOTHIAZINONE DERIVATIVE SUBSTITUTED WITH TRIFLUOROMETHYL AT 6-POSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#368FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1
#369SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF
#370ULTRAVIOLET AND VISIBLE RADIATION ABSORBING COMPOUNDS
#371MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS
#372(HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT
#373Anilino-Pyrazole Derivatives, Compositions and Methods Thereof
#374SOLID STATE FORMS OF LANIFIBRANOR AND PROCESS FOR PREPARATION THEREOF
#375ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS
#376COMPOUNDS AS PD1/PD-L1 INHIBITORS AND METHODS THEREOF
#377EBNA1 Inhibitors and Methods Using Same
#378Aryl-OR heteroaryl-substituted benzene compounds
#379Aryl-or heteroaryl-substituted benzene compounds
#380Papain-like protease (PLpro) inhibitors
#381COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
#3823-AMINO PIPERIDYL SODIUM CHANNEL INHIBITORS
#383PPARG INVERSE AGONISTS AND USES THEREOF
#384ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS
#385BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5
#386INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
#387INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
#388PROTEASE INHIBITORS AND METHODS OF MAKING SAME
#389PREPARATION METHOD FOR BICYCLIC COMPOUND AND APPLICATION AS ANTIFUNGAL AGENT
#390INHIBITORS OF PLASMA KALLIKREIN
#391COMPOUNDS AND METHODS FOR MODULATING SPLICING
#392PHARMACEUTICAL COMPOUND
#393INHIBITORS OF KINASE NETWORKS AND USES THEREOF
#394AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS
#395THIAZOLE/ISOTHIAZOLE HSD17B13 INHIBITORS AND USES THEREOF
#396WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE
#397SUBSTITUTED QUINOLINE DERIVATIVES HAVING SOS1 INHIBITION ACTIVITIES AND USES THEREOF
#398NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
#399DIACYLGLYCEROL KINASE MODULATING COMPOUNDS
#400SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS
#401COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA
#402INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF
#403SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES
#404CDK INHIBITORS AND METHODS OF USE THEREOF
#405PYRIDAZINONES AS PARP7 INHIBITORS
#406INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION
#407COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#408TREATMENTS FOR DIABETIC NEUROPATHY
#409INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
#410OX2R Compounds
#411HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#412KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#413NOVEL INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#414Aldehyde Dehydrogenase Inhibitors and Their Therapeutic Use
#415COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES
#416ARYLSULFONAMIDES AS OREXIN RECEPTOR AGONISTS
#417COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME
#418BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS
#419COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
#420DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#421COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#422Compounds, Compositions and Methods
#423Lysine acetyltransferase 6A (KAT6A) inhibitors and uses thereof
#424NOVEL COMPOUNDS COMPRISING A NEW CLASS OF TRANSTHYRETIN LIGANDS FOR TREATMENT OF COMMON AGE-RELATED COMORBIDITIES
#425Human plasma kallikrein inhibitors
#426Human plasma kallikrein inhibitors
#427Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof
#428HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF
#429FUSED HETEROBICYCLIC ANTIVIRAL AGENTS
#430PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS
#431HBV INHIBITOR AND ITS USE
#432RNF4 TARGETING COMPOUNDS AND USES THEREOF
#433HETEROCYCLIC CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF
#434INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
#435Substituted heterocycles as aldehyde dehydrogenase inhibitors
#436NLRP3 INFLAMMASOME SMALL-MOLECULE INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE
#437Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#438Compounds and methods for inhibiting fascin
#439INJECTABLE LURASIDONE SUSPENSION AND PREPARATION METHOD THEREFOR
#440COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS
#441METHOD FOR PREPARING AN ENANTIOMERICALLY ENRICHED FORM OF 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-HYDROXY-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE
#442Heterocycles as WIP1 Inhibitors
#443ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
#444BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT
#445BENZOTHIAZOLE AND QUINOLINE DERIVATIVES AND THEIR USE
#446PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING
#447MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#4482,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT
#449LYSINE ACETYLTRANSFERASE 6A (KAT6A) INHIBITORS AND USES THEREOF
#450SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
#451ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USE
#452ACRYLAMIDE COMPOUNDS
#453HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#454METHOD FOR PREPARING 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-OXO-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE
#455HETEROARYL-ACETYLENES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#456ERAP INHIBITORS
#457Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins
#458MU-OPIOID RECEPTOR AGONISTS AND USES THEREFOR
#459MASP-2 INHIBITORS AND METHODS OF USE
#460DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES
#461CRYSTAL FORM OF LANIFIBRANOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#462Heterocycle RMB39 Modulators
#463(CYANO-DIMETHYL-METHYL)-ISOXAZOLES AND -[1,3,4]THIADIAZOLES
#464PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#465CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY
#466DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#4672-Methyl-Quinazolines
#468TEAD INHIBITORS AND USES THEREOF
#469MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#470Compositions and methods for treating cancer
#471Inhibitors of NLRP3 inflammasome
#472COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR
#473NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF
#474INHIBITORS OF NLRP3 INFLAMMASOME
#475HMOX1 inducers
#476HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
#477ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE
#478PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF
#479INHIBITORS OF NLRP3 INFLAMMASOME
#480COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING
#481cGAS antagonist compounds
#482INHIBITORS OF PU.1 FOR THE TREATMENT OF DISEASE
#483HEPATITIS B CORE PROTEIN MODULATORS
#484AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
#485SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES
#486INHIBITORS OF NO PRODUCTION
#487COMPOUND HAVING INHIBITORY ACTIVITY AGAINST O-GLUSACASE AND USE THEREOF
#488MODULATORS OF THE INTEGRATED STRESS PATHWAY
#489MAGL INHIBITORS
#490CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS
#491Aminothiazole Compounds as Inhibitors of CTPS1
#492MODULATORS OF PROGRAMMED DEATH-LIGAND-1
#493N-Linked Glycosylation Inhibitors and Methods of Using Same
#4945-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY
#495BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR
#496Compounds and compositions for treating conditions associated with NLRP activity
#497COMPOUNDS, COMPOSITIONS, AND METHODS
#498TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
#499PCSK9 INHIBITORS AND METHODS OF USE THEREOF
#500Compound and use thereof in treating autoimmune diseases
#501LIGANDS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) CONTAINING HETEROAROMATIC LINKER BUILDING BLOCKS
#502EIF4E inhibitors and uses thereof
#503INTERLEUKIN-17 INHIBITORS
#504Novel Compounds
#505BENZOTHIAZOLYL BICYCLO[1.1.1]PENTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
#5061,4-substituted piperidine derivatives
#507SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF
#508RILUZOLE PRODRUGS AND THEIR USE
#509Riluzole prodrugs and their use
#510KINASE MODULATORS AND METHODS OF USE THEREOF
#511MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#512HETEROCYCLIC AMIDES AND THEIR USE FOR MODULATING SPLICING
#513BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS
#514Antiviral compounds
#515CARBOXYLIC DIARYLTHIAZEPINEAMINES AND USES THEREOF
#516INHIBITORS OF NLRP3 INFLAMMASOME
#517Heterocyclic mitochondrial activity inhibitors and uses thereof
#518MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS
#519ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE
#520CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE
#521PYRAZOLE ACYLHYDRAZONE CONTAINING TRIFLUOROMETHYLTHIADIAZOLE UNITS, PREPARATION METHOD AND USE THEREOF
#522Inhibitors of Glucose-6-phosphate Dehydrogenase and Uses Thereof
#523Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
#524Bicyclic-fused heteroaryl or aryl compounds
#525PLANT GROWTH REGULATOR COMPOUNDS
#526AMINO ALCOHOL COMPOUNDS AND USES THEREOF
#527SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
#528CRYSTAL OF COMPOUND X7 HYDROCHLORIDE AND ITS PREPARATION METHOD AND APPLICATION
#529IRAK INHIBITORS AND USES THEREOF
#530QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
#531Inhibitors of protein tyrosine phosphatase, compositions, and methods of use
#532COMPOUNDS AND FORMULATIONS FOR TREATING OPHTHALMIC DISEASES
#5331-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE AS USP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS
#534N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides
#535Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
#536Compounds useful for inhibiting RET kinase
#5372-OXO-IMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS
#538N-SUBSTITUTED 4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)ANILINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
#539MCL-1 inhibitors
#540SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF
#541METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#542ARYLSULFONYL DERIVATIVES AND THEIR USE AS MUSCARINIC ACETYLCHOLINE RECEPTOR M5 INHIBITORS
#543LMO2 PROTEIN INHIBITORS
#544ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF
#545DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE DERIVATIVES COMPOUNDS
#546Protein degraders and uses thereof
#547MONOBACTAM COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
#548Aryl hydrocarbon receptor (AHR) agonists and uses thereof
#549COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING
#550ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
#551NEW PqsR INVERSE AGONISTS
#552N -SUBSTITUTED 4-(1,3-ARYLOXAZOLO-2-YL)PHENYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
#5532-PHENYLBENZOTRIAZOL-5-AMINE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS (HBV) INFECTION
#554PHENYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR
#555PTGR2 inhibitors and their use
#556Compounds for Improving mRNA Splicing
#557BICYCLO[1.1.1]PENTANE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
#558Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#559NOVEL CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS COMPRISING 2 OR MORE ARYL OR HETEROARYL CONNECTED VIA LINKER AND USE THEREOF
#560TREX1 INHIBITORS AND USES THEREOF
#561Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
#562Organic electric element
#563COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#564Method of the preparation of fused multicyclic compounds
#565RET kinase inhibitors
#566PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#567SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#568CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS
#569COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#570Compositions and methods for treating cancer
#571Compound, tautomer of compound or salt of compound or tautomer, method for producing same, coloring composition, dyeing method, and dyed article
#572SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
#573MALONITRILE DERIVATIVES
#574IRAK DEGRADERS AND USES THEREOF
#575CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS
#576Modulators of cystic fibrosis transmembrane conductance regulator
#577PYRIMIDINE COMPOUND AS AXL INHIBITOR
#578BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS
#579BENZAMIDE COMPOUND AND USE THEREOF
#580BETA-LACTAM COMPOUND, USE THEREOF AND PREPARATION METHOD THEREFOR
#5812-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORS
#582Aryl cyclopropyl-amino-isoquinolinyl amide compounds
#583QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#584MODULATORS OF E3 LIGASES
#5855-OXOPYRROLIDINE-3-CARBOXAMIDES AS NAV1.8 INHIBITORS
#586Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
#587Substituted carboxamides as inhibitors of WDR5 protein-protein binding
#588BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
#589NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#590Pyrazole MAGL inhibitors
#591Cannabinoid receptor mediating compounds
#592NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE
#593PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS
#594INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#595COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
#596Compounds and methods for the enhanced degradation of targeted proteins
#597PESTICIDAL COMPOSITIONS AND METHODS
#598ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A
#599THIAZOLOXIME AND OXAZOLOXIME DERIVATIVES AS REACTIVATORS OF ORGANOPHOSPHOROUS NERVE AGENT (OPNA)-INHIBITED HUMAN ACETYLCHOLINESTERASE FOR THE TREATMENT OF NERVOUS AND/OR RESPIRATORY FAILURE AFTER INTOXICATION WITH OPNA
#600DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES